A mutation in IDH1 or IDH2 causes the accumulation of 2-hydroxyglutarate (2-HG) and inhibits TET2 enzyme activity, resulting increased DNA methylation that drives AML progression (Lu et al., 2012). This evidence concerns the gene IDH2 and acute myeloid leukemia.